Wire flash
Oujiahua Warns After Four Consecutive Limit-Up Days: Health Service Robot Business Still in Exploration
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Oujiawei (stock code: 002614) issued a risk warning on September 27 after its stock price surged 46.65% over four consecutive trading days, closing at 8.33 yuan per share with a total market capitalization of 5.196 billion yuan. The company stated that its health service robot business remains in an exploratory stage and has not yet entered the humanoid robot field, with significant uncertainty. It also noted that some health care products can be used in elderly care scenarios but account for a small portion of revenue, having limited impact on overall performance. Additionally, while some export business involves RCEP member countries, the overall benefit is limited and has not materially affected operating results. The stock experienced abnormal trading volatility on September 23 and 24, with cumulative closing price deviations exceeding 20%.
Source report
After achieving four consecutive daily limit-ups in the secondary market, OGAWAA (奥佳华) disclosed an announcement on the evening of September 27, stating that its stock had hit the daily limit-up for four consecutive trading days from September 21 to September 24, with a cumulative increase of approximately 46.65%. The short-term rise was significant.
The company noted that the cumulative deviation of its closing price exceeded 20% over two consecutive trading days (September 23 and September 24), which constitutes abnormal stock trading volatility.
Market Performance
As of the close on September 24, OGAWAA's stock price ended at the daily limit-up of RMB 8.33 per share, with a total market capitalization of RMB 5.196 billion.
Company Clarification
OGAWAA stated the following:
- The company's health service robot-related business is still in the exploratory stage and has not yet involved the humanoid robot sector. The relevant situation remains uncertain.
- Certain health and care products offered by the company can be applied in elderly care scenarios and are part of the elderly care industry chain. However, their revenue contribution is not significant and has a limited impact on the company's overall operating performance.
- Some of the company's export business involves RCEP member countries, but the overall benefit is limited and has not yet had a material impact on the company's operating results.
Source
北京商报Neutral / independent
Part of this Story
Oujiawan shares surge 46% in four days, then plunge; company warns of speculative risks